Your browser doesn't support javascript.
loading
The persistence and antitumor efficacy of CAR-T cells are modulated by tonic signaling within the CDR.
Zhou, Jincai; Shi, Feifei; Luo, Xinran; Lei, Bixia; Shi, Zhongjun; Huang, Chenyu; Zhang, Yuting; Li, Xiaopei; Wang, Huajing; Li, Xian-Yang; He, Xiaowen.
Afiliação
  • Zhou J; R&D Department, OriCell Therapeutics Co. Ltd., 1227 Zhangheng Road, Shanghai, 201203, China. Electronic address: zhoujincai@oricell.com.
  • Shi F; R&D Department, OriCell Therapeutics Co. Ltd., 1227 Zhangheng Road, Shanghai, 201203, China.
  • Luo X; R&D Department, OriCell Therapeutics Co. Ltd., 1227 Zhangheng Road, Shanghai, 201203, China.
  • Lei B; R&D Department, OriCell Therapeutics Co. Ltd., 1227 Zhangheng Road, Shanghai, 201203, China.
  • Shi Z; R&D Department, OriCell Therapeutics Co. Ltd., 1227 Zhangheng Road, Shanghai, 201203, China.
  • Huang C; R&D Department, OriCell Therapeutics Co. Ltd., 1227 Zhangheng Road, Shanghai, 201203, China.
  • Zhang Y; R&D Department, OriCell Therapeutics Co. Ltd., 1227 Zhangheng Road, Shanghai, 201203, China.
  • Li X; R&D Department, OriCell Therapeutics Co. Ltd., 1227 Zhangheng Road, Shanghai, 201203, China.
  • Wang H; R&D Department, OriCell Therapeutics Co. Ltd., 1227 Zhangheng Road, Shanghai, 201203, China.
  • Li XY; R&D Department, OriCell Therapeutics Co. Ltd., 1227 Zhangheng Road, Shanghai, 201203, China. Electronic address: lixianyang@oricell.com.
  • He X; R&D Department, OriCell Therapeutics Co. Ltd., 1227 Zhangheng Road, Shanghai, 201203, China. Electronic address: peterhe@oricell.com.
Int Immunopharmacol ; 126: 111239, 2024 Jan 05.
Article em En | MEDLINE | ID: mdl-37979453

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Receptores de Antígenos Quiméricos Limite: Humans Idioma: En Revista: Int Immunopharmacol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Receptores de Antígenos Quiméricos Limite: Humans Idioma: En Revista: Int Immunopharmacol Ano de publicação: 2024 Tipo de documento: Article